Hypertension in 2016: Blood pressure goals, variability and SGLT2 blockade in CKD

Nature Reviews Nephrology 13, 75 (2017). doi:10.1038/nrneph.2016.189 Authors: Debbie L. Cohen & Raymond R. Townsend Blood pressure (BP) goals and the management of BP in patients with chronic kidney disease (CKD) remain controversial topics. Key articles in the past year have addressed BP goals in CKD, the use of new agents to slow CKD progression and the effects of visit-to-visit variability in systolic BP on cardiovascular events and renal progression in patients with CKD.
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Tags: Year in Review Source Type: research